國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Liquid biopsies in solid tumors

Cristofanilli, Massimo.

Liquid biopsies in solid tumors

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Liquid biopsies in solid tumorsedited by Massimo Cristofanilli.
其他作者:	Cristofanilli, Massimo.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	x, 161 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	TumorsDiagnosis.
電子資源:	http://dx.doi.org/10.1007/978-3-319-50956-3
ISBN:	9783319509563$q(electronic bk.)

Liquid biopsies in solid tumors
Liquid biopsies in solid tumors[electronic resource] /edited by Massimo Cristofanilli. - Cham :Springer International Publishing :2017. - x, 161 p. :ill., digital ;24 cm. - Cancer drug discovery and development,2196-9906. - Cancer drug discovery and development..

1.Blood-based diagnostics in solid tumors: an overview -- 2.Circulating tumor cells (CTCs) in primary disease: the seed for metastasis -- 3.Enumeration and molecular analysis of CTCs in metastatic disease: The breast cancer model -- 4.Epithelial-Mesenchymal Transition (EMT) and cancer stem cells (CSCs): The traveling metastasis -- 5.Detection and monitoring of circulating immune cells in solid tumors: shifting priorities -- 6.Circulating-free tumor DNA (ctDNA): the real-time liquid biopsy -- 7.CTCs and ctDNA: two tales of a complex biology -- 8.Exosome: decoding the messaging system.

This volume, with chapters written by experts in the field of cancerous tumors, details the key factors associated with liquid biopsies in solid tumors: blood-based diagnostics; circulating tumor cells; enumeration and molecular analysis (association with breast cancer); epithelialmesenchymal transition; detection and monitoring; circulating-free tumor DNA; CTCs and ctDNA; and the exosome. The field of blood-based diagnostics is rapidly evolving demonstrating the possibility of real-time molecular analysis of cancer cells and their phenotype and genotype. Circulating Tumor Cell (CTCs) have demonstrated prognostic and predictive value in advanced cancer and represents a source of tumor cells for transcriptome and genomic analysis. Most recently, the detection of genomic abnormalities in the peripheral blood by sensitive and selective PCR methods (liquid biopsy) opened to the option of a comprehensive blood-based tumor analysis. Similar information can be obtained by analysis of exosome, a natural packaging and messaging system being explored in advanced malignancies. The final frontier is the evaluation of immune cells determinant of innate and adaptive immunity.

ISBN: 9783319509563$q(electronic bk.)

Standard No.: 10.1007/978-3-319-50956-3doiSubjects--Topical Terms:

468368
Tumors
--Diagnosis.

LC Class. No.: RC255

Dewey Class. No.: 616.9940758

Liquid biopsies in solid tumors
LDR:02744nmm a2200325 a 4500 001 509360
003 DE-He213
005 20170325102247.0
006 m d
007 cr nn 008maaau
008 171121s2017 gw s 0 eng d
020 $a 9783319509563$q(electronic bk.)
020 $a 9783319509556$q(paper)
024 7 $a 10.1007/978-3-319-50956-3 $2 doi
035 $a 978-3-319-50956-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC255
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.9940758 $2 23
090 $a RC255 $b .L767 2017
245 0 0 $a Liquid biopsies in solid tumors $h [electronic resource] / $c edited by Massimo Cristofanilli.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2017.
300 $a x, 161 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer drug discovery and development, $x 2196-9906
505 0 $a 1.Blood-based diagnostics in solid tumors: an overview -- 2.Circulating tumor cells (CTCs) in primary disease: the seed for metastasis -- 3.Enumeration and molecular analysis of CTCs in metastatic disease: The breast cancer model -- 4.Epithelial-Mesenchymal Transition (EMT) and cancer stem cells (CSCs): The traveling metastasis -- 5.Detection and monitoring of circulating immune cells in solid tumors: shifting priorities -- 6.Circulating-free tumor DNA (ctDNA): the real-time liquid biopsy -- 7.CTCs and ctDNA: two tales of a complex biology -- 8.Exosome: decoding the messaging system.
520 $a This volume, with chapters written by experts in the field of cancerous tumors, details the key factors associated with liquid biopsies in solid tumors: blood-based diagnostics; circulating tumor cells; enumeration and molecular analysis (association with breast cancer); epithelialmesenchymal transition; detection and monitoring; circulating-free tumor DNA; CTCs and ctDNA; and the exosome. The field of blood-based diagnostics is rapidly evolving demonstrating the possibility of real-time molecular analysis of cancer cells and their phenotype and genotype. Circulating Tumor Cell (CTCs) have demonstrated prognostic and predictive value in advanced cancer and represents a source of tumor cells for transcriptome and genomic analysis. Most recently, the detection of genomic abnormalities in the peripheral blood by sensitive and selective PCR methods (liquid biopsy) opened to the option of a comprehensive blood-based tumor analysis. Similar information can be obtained by analysis of exosome, a natural packaging and messaging system being explored in advanced malignancies. The final frontier is the evaluation of immune cells determinant of innate and adaptive immunity.
650 0 $a Tumors $x Diagnosis. $3 468368
650 0 $a Tumors $x Molecular diagnosis. $3 776133
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
700 1 $a Cristofanilli, Massimo. $3 560876
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer drug discovery and development. $3 557535
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-50956-3
950 $a Medicine (Springer-11650)